Glycans can be linked to any type of antigen or vehicle that contains the antigen, opening a wealth of applications. Our approach allows the development of novel antigen based products. In addition, pipeline and existing antigen derived products are candidates for improvement by GlycoDCTM.
Targeting Dendritic Cells with glycans to induce immunity finds applications in prophylactic vaccines and therapeutic cancer vaccines. Targeting Dendritic Cells with glycans to induce tolerance finds applications in allergy, auto-immune diseases and inflammation.
More detailed information on the application in specific therapeutic and health areas:
- THERAPEUTIC CANCER VACCINES
- PROPHYLACTIC VACCINES
- FOOD ALLERGY PRODUCTS
- ALLERGY THERAPEUTICS
- AUTOIMMUNE THERAPEUTICS
- INFLAMMATION THERAPEUTICS